- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05055596
Improving Quality of Life for Adults Living With HIV and Chronic Pain
February 24, 2026 updated by: Temple University
Chronic pain is highly comorbid among the 1.2 million persons living with HIV, with recent prevalence estimates ranging from 55-67%.
Needed are evidenced-based non-pharmacological interventions to improve chronic pain management and reduce the demand for opioids in the United States.
The proposed research will address this need by examining the feasibility and acceptability of Tai Chi as a mind-body intervention for chronic pain management in an HIV population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Persons living with HIV (PLWH) are at increased risk for chronic pain conditions, with prevalence rates estimated to be between 55-67%.
While acute pain is a life-sustaining biological response to tissue damage or injury, chronic pain is a separate condition that often causes significant physical and psychological suffering.
Causes of chronic pain among PLWH include disease progression, the impact of the virus on immune and nervous system function, and medication side-effects.
PLWH, like many other chronic pain patients, may be prescribed opioid medications, which have not been found to be effective in managing non-cancer related chronic pain.
Additionally, the significant risk of dependence and overdose far outweigh the potential benefit of opioid medications for chronic pain.
Governing bodies in medicine have called for non-pharmacological interventions to be considered front-line treatment recommendations for chronic pain management.
Mind-body interventions, such as mindfulness, yoga, and Tai Chi, have been shown to be effective at reducing pain symptoms and improving psychological outcomes for individuals with chronic pain.
Unfortunately, few studies have examined the use of mind-body interventions for chronic pain management for PWLH, with even fewer using formative research to modify interventions to meet the unique needs of this vulnerable population.
The research plan proposed in this application will address these gaps in the literature.
This study will examine the feasibility and acceptability of a mind-body intervention, Qigong/Tai Chi Easy, for chronic pain management among PLWH.
The researchers will recruit 40 individuals from the Comprehensive HIV Program at Temple Health.
Following informed consent, participants will be randomized to mind-body arm or health education control arm.
Participants in both arms will complete baseline assessment followed by a 10-week intervention.
The mind-body intervention group will meet weekly for 60-minute sessions and be provided with a video for at-home practice.
The health education group will also meet weekly for 60 minutes and be assigned weekly homework related to the topics discussed in session.
At the conclusion of the 10 weeks, participants will complete at post-intervention assessment.
A 3-month follow up assessment will also be completed.
In addition to feasibility (i.e., recruitment rates, retention) and acceptability (i.e., satisfaction ratings), the researchers will assess pain symptoms (general and specific), perceived stress, depression, quality of life, and HIV medication adherence.
The researchers anticipate that the study will demonstrate feasibility and acceptability as evidenced by adequate enrollment, retention, and satisfaction.
Findings from the proposed study will be used to inform a future research grant with power to detect efficacy of the mind-body intervention for chronic pain management.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Kornberg School of Dentistry (TUKSoD)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 45 and older;
- HIV positive status based on clinical records;
- chronic pain condition based on clinical records;
- English speaking;
- physically able to participate in a Tai Chi program
Exclusion Criteria:
- Inability or unwillingness to provide informed consent
- Inability or unwillingness to travel to Temple Dental School;
- Inability or unwillingness to engage in 10-week intervention;
- Non-English speaking;
- Active substance use disorder;
- Acutely suicidal or psychotic;
- Self-reported participation in another research study related to chronic-pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Gentle Movement
This is the active intervention arm.
Qigong/Tai Chi Easy is a manualized intervention with formal training for instructors through the Institute of Integral Qigong and Tai Chi (IIQTC).
The protocol can be modified based on participant needs and physical abilities.
Qigong/Tai Chi Easy uses a series of repeated and simple-to-learn movements (rather than long forms with complicated choreography).
|
Qigong/Tai Chi Easy is a manualized intervention with formal training for instructors through the Institute of Integral Qigong and Tai Chi (IIQTC).
The protocol can be modified based on participant needs and physical abilities.
Qigong/Tai Chi Easy uses a series of repeated and simple-to-learn movements (rather than long forms with complicated choreography).
|
|
Active Comparator: Health Coaching
This is the time and attention active comparator control group arm: The Health Education group will be adapted from a previously developed time and attention control condition used in HIV research.
Additional health education material will be based on information learned in the qualitative interviews conducted prior to the start of this study.
Examples of session material include the following: sleep hygiene, healthy diet, sun safety, and healthy homes.
|
The Health Education group will be adapted from a previously developed time and attention control condition used in HIV research.
Additional health education material will be based on information learned in the qualitative interviews conducted prior to the start of this study.
Examples of session material include the following: sleep hygiene, healthy diet, sun safety, and healthy homes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Intensity - Brief Pain Inventory
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
Participants will be asked to rate their pain, ranging from 0, no pain, to 10, most extreme pain, on average in the past week.
Higher scores indicate worse pain.
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
|
Pain Interference - Brief Pain Inventory
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
A self-report of impairment in mobility, impairment in activities of daily living, mood, and pain-related anxiety/fear.
The pain interference subscale score is the average of 7 items, with responses that range from 0-10.
Higher scores indicate worse pain interference.
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
|
Feasibility to Execute Study Protocol
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
Ability to recruit and retain participants through intervention and follow-up assessments
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
|
Participant Satisfaction Questionnaire (PSQ) - Acceptability
Time Frame: Post-Intervention (Weeks 10-12)
|
Participant self-reported satisfaction with intervention components.
Response to question: "How would you rate your overall satisfaction with this program?"
|
Post-Intervention (Weeks 10-12)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perceived Stress Scale (PSS)
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
The Perceived Stress Scale is a measure of self-reported stress in the past month.
There are 13 items and responses range from 0 (never) to 4 (very often).
A total score is calculated and can range from 0 to 52, with higher scores indicated a greater degree of perceived stress.
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
|
Patient Health Questionnaire (PHQ-8)
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
The PHQ-9 is a commonly used measure of depression with strong psychometric properties for clinical populations.
The scale consists of 8 items, with responses ranging from 0 (not at all) to 3 (nearly every day).
Total scores are calculated and possible scores range from 0 to 24, with higher scores indicated more depressive symptoms.
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility
Time Frame: Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
Ability to recruit and retain participants through intervention and follow-up assessments
|
Baseline (Week 0), Post-Intervention (Weeks 10-12), 3-month Follow Up (Weeks 22-24)
|
|
Acceptability
Time Frame: Post-Intervention (Weeks 10-12)
|
Participant self-reported satisfaction with intervention components
|
Post-Intervention (Weeks 10-12)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Eugene M Dunne, PhD, Temple University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2021
Primary Completion (Actual)
December 15, 2023
Study Completion (Actual)
December 15, 2023
Study Registration Dates
First Submitted
September 2, 2021
First Submitted That Met QC Criteria
September 15, 2021
First Posted (Actual)
September 24, 2021
Study Record Updates
Last Update Posted (Actual)
March 18, 2026
Last Update Submitted That Met QC Criteria
February 24, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Pain
- Neurologic Manifestations
- Immune System Diseases
- Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- HIV Infections
- Chronic Pain
- Therapeutics
- Mind-Body Therapies
- Complementary Therapies
- Exercise Movement Techniques
- Physical Therapy Modalities
- Tai Ji
Other Study ID Numbers
- K23AT010099 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CAN Community HealthGilead Sciences; Midway Specialty Care Center; Costello Medical Inc.Not yet recruitingHIV | HIV 1 Infection | HIV -1 Infection | HIV (Human Immunodeficiency Virus)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV Infections | HIV SeronegativityUnited States, Puerto Rico
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
Clinical Trials on Tai Chi
-
Harvard University Faculty of MedicineBeth Israel Deaconess Medical Center; Brigham and Women's HospitalCompleted
-
Lidian ChenPeking University Third HospitalNot yet recruiting
-
Chengdu University of Traditional Chinese MedicineNot yet recruitingQuality of Life | Dialysis; Complications | Chinese Medicine
-
Jinan University GuangzhouChaozhou Special Education SchoolCompleted
-
University Hospital, Clermont-FerrandCompleted
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Hartford HospitalRecruiting
-
Texas Tech University Health Sciences CenterCompleted
-
Chang Gung Memorial HospitalCompleted
-
Massachusetts General HospitalUnknown